Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-31T23:04:50.810Z Has data issue: false hasContentIssue false
  • English
  • Français

Lipase inhibition attenuates the acute inhibitory effects of oral fat on food intake in healthy subjects

Published online by Cambridge University Press:  09 March 2007

Deirdre O'Donovan ,
Christine Feinle-Bisset ,
Judith Wishart  and
Michael Horowitz
Deirdre O'Donovan
Affiliation:
Department of Medicine, University of Adelaide, Royal Adelaide Hospital, North Terrace, South Australia 5000, Australia
Christine Feinle-Bisset*
Affiliation:
Department of Medicine, University of Adelaide, Royal Adelaide Hospital, North Terrace, South Australia 5000, Australia
Judith Wishart
Affiliation:
Department of Medicine, University of Adelaide, Royal Adelaide Hospital, North Terrace, South Australia 5000, Australia
Michael Horowitz
Affiliation:
Department of Medicine, University of Adelaide, Royal Adelaide Hospital, North Terrace, South Australia 5000, Australia
*
*Corresponding author: Dr Christine Feinle-Bisset, fax +61 8 82233870, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The lipase inhibitor, orlistat, is used in the treatment of obesity and reduces fat absorption by about 30%. However, the mean weight loss induced by orlistat is less than expected for the degree of fat malabsorption. It was hypothesised that lipase inhibition with orlistat attenuates the suppressive effects of oral fat on subsequent energy intake in normal-weight subjects. Fourteen healthy, lean subjects (nine males, five females; aged 25±1·3 years) were studied twice, in a double-blind fashion. The subjects received a high-fat yoghurt ‘preload’ (males 400g (2562kJ); females 300g (1923kJ)), containing orlistat (120mg) on one study day (and no orlistat on the other ‘control’ day), 30min before ad libitum access to food and drinks; energy intake was assessed during the following 8h. Blood samples were taken at regular intervals for the measurement of plasma cholecystokinin (CCK). Each subject performed a 3d faecal fat collection following each study. Energy intake during the day was greater following orlistat (10220 (sem 928) kJ) v. control (9405 (sem 824) kJ) (P=0·02). On both days plasma CCK increased (P<0·05) after the preload. Plasma CCK 20min following ingestion of the preload was less after orlistat (4·1 (sem 0·9) pmol/l) v. control (5·3) (sem 0·9) pmol/l (P=0·028); however there was no difference in the area under the curve 0–510min between the two study days. Fat excretion was greater following orlistat (1017 (sem 168) kJ) v. control (484 (sem 90) kJ) (P=0·004). In conclusion, in healthy, lean subjects the acute inhibitory effect of fat on subsequent energy intake is attenuated by orlistat and the increase in energy intake approximates the energy lost due to fat malabsorption.

Keywords

OrlistatLipase inhibitionEnergy intakeCholecystokininFaecal fat
Type
Short communication
Information
British Journal of Nutrition , Volume 90 , Issue 5 , November 2003 , pp. 849 - 852
Copyright
Copyright © The Nutrition Society 2003

References

Beckoff, K, MacIntosh, CG & Chapman, IM (2001) Effects of glucose supplementation on gastric emptying, blood glucose homeostasis, and appetite in the elderly. Am J Physiol 280, R570–R576.Google ScholarPubMed
Beglinger, C, Degen, L, Matzinger, D, D'Amato, M & Drewe, J (2001) Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans. Am J Physiol 280, R1149–R1154.Google ScholarPubMed
Chapman, IM, Goble, EA, Wittert, GA & Horowitz, M (1999) Effects of small-intestinal fat and carbohydrate infusions on appetite and food intake in obese and nonobese men. Am J Clin Nutr 69, 6–12.CrossRefGoogle ScholarPubMed
Feinle, C, O'Donovan, D & Doran, S (2003) Effects of fat digestion on appetite, APD motility, and gut hormones in response to duodenal fat infusion in humans. Am J Physiol 284, G798–G807.Google ScholarPubMed
Franson, K & Rossner, S (2000) Fat intake and food choices during weight reduction with diet, behavioural modification and a lipase inhibitor. J Intern Med 247, 607–614.CrossRefGoogle Scholar
Garner, DM, Olmsted, MP, Bohr, Y & Garfinkel, PE (1982) The eating attitudes test: psychometric features and clinical correlates. Psychol Med 12, 871–878.CrossRefGoogle ScholarPubMed
Hill, JO, Hauptman, J & Anderson, JW (1999) Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. Am J Clin Nutr 69, 1108–1116.CrossRefGoogle ScholarPubMed
Klein, S (1999) The war against obesity: attacking a new front. Am J Clin Nutr 69, 1061–1063.CrossRefGoogle ScholarPubMed
MacIntosh, CG, Horowitz, M & Verhagen, MA (2001 a) Effect of small intestinal nutrient infusion on appetite, gastrointestinal hormone release, and gastric myoelectrical activity in young and older men. Am J Gastroenterol 96, 997–1007.CrossRefGoogle Scholar
MacIntosh, CG, Morley, JE & Wishart, J (2001 b) Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: Evidence for increased CCK activity as a cause of the anorexia of aging. J Clin Endocrinol Metab 86, 5830–5837.CrossRefGoogle Scholar
Matzinger, D, Degen, L & Drewe, J (2000) The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut 46, 688–693.CrossRefGoogle ScholarPubMed
Meyer, JH, Hlinka, M, Tabrizi, Y, DiMaso, N & Raybould, HE (1998) Chemical specificities and intestinal distributions of nutrient-driven satiety. Am J Physiol 275, R1293–R1307.Google ScholarPubMed
Read, N, French, S & Cunningham, K (1994) The role of the gut in regulating food intake in man. Nutr Rev 52, 1–10.CrossRefGoogle ScholarPubMed
Shide, DJ, Caballero, B, Reidelberger, R & Rolls, BJ (1995) Accurate energy compensation for intragastric and oral nutrients in lean males. Am J Clin Nutr 61, 754–764.CrossRefGoogle ScholarPubMed
Stunkard, AJ & Messick, S (1985) The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 29, 71–83.CrossRefGoogle ScholarPubMed
Zhi, J, Massarella, JW & Melia, AT (1994) The pharmacokinetic-pharmacodynamic (Digit Symbol Substitution Test) relationship of flumazenil in a midazolam steady-state model in healthy volunteers. Clin Pharmacol Ther 56, 530–536.CrossRefGoogle Scholar
Zung, WW, Richards, CB & Short, MJ (1965) Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry 13, 508–515.CrossRefGoogle Scholar